| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/16/2003 | EP1326604A2 Combination of at least two compounds selected from an at1-receptorantagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups |
| 07/16/2003 | EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS |
| 07/16/2003 | EP1253933B1 Use of neurotoxins in medicaments for thyroid disorders |
| 07/16/2003 | EP1104675A4 Agent for regulating iodine exchange or for preventing iodine-deficit conditions |
| 07/16/2003 | EP1076558B1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens |
| 07/16/2003 | CN1430624A Novel solid body forms of mesoprogestin 11-beta-[4E-(hydroxyimino methyl)-phenyl]-17-alpha-methoxy methyl-17 beta-methoxy-estra-4,9-dien-3-one |
| 07/16/2003 | CN1430620A Macrolides compound |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430502A Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593345 Naphthyl compounds, intermediates, compositions, and methods of use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593317 Progestin therapy for maintaining amenorrhea |
| 07/15/2003 | US6593296 Stabilized growth hormone formulation and method of preparation thereof |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6592910 Methods of treating clinical diseases with isoflavones |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
| 07/10/2003 | WO2003056029A2 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 07/10/2003 | WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 07/10/2003 | WO2003055984A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 07/10/2003 | WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 07/10/2003 | WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/10/2003 | WO2003055510A1 Therapy for growth hormone induced insulin resistance in juveniles with growth disorders |
| 07/10/2003 | WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION |
| 07/10/2003 | WO2003055482A1 Amide derivatives as gk activators |
| 07/10/2003 | WO2003055462A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003055440A2 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | WO2003015872A3 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders |
| 07/10/2003 | WO2003002175A8 Enhanced systemic absorption of intradermally delivered substances |
| 07/10/2003 | WO2002046409A3 Proteins and nucleic acids encoding same |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130347 Such as 6-methoxy-2-(4-methoxyphenyl)-1-(2-propenyl)-napthalene for oral administration with improved absorption; antiestrogens; antitumor agents |
| 07/10/2003 | US20030130340 Novel benzothiophene derivatives |
| 07/10/2003 | US20030130335 Protein tyrosine phosphatases inhibitors |
| 07/10/2003 | US20030130284 Animal growth regulators; osteoporosis; congestive heart failure; muscular disorders |
| 07/10/2003 | US20030130283 CRF receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents |
| 07/10/2003 | US20030130243 Hormone replacement therapy |
| 07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129172 Animal growth regulator |
| 07/10/2003 | US20030129141 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
| 07/10/2003 | CA2472121A1 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 07/10/2003 | CA2471601A1 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 07/10/2003 | CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | CA2457801A1 Streptococcus thermophilus strain and use thereof |
| 07/09/2003 | EP1325914A1 Tetrahydroquinoline compounds |
| 07/09/2003 | EP1325909A1 Tricyclic indole compounds having affinity for serotonin receptor |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324754A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
| 07/09/2003 | EP1173151B1 Dry, mouldable drug formulation |
| 07/09/2003 | CN1429224A Novel benzothiophene derivatives |
| 07/09/2003 | CN1429223A Novel benzofuran derivatives |
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589560 Stable glassy state powder formulations |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003053994A1 Tetrahydrobenzfluorene derivatives |
| 07/03/2003 | WO2003053993A1 Androgenic 14.alpha, 17.alpha-ethenosteroids |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053928A1 Serotonine reuptake inhibitor |
| 07/03/2003 | WO2003053920A1 Crystals of bicalutamide and process for their production |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053325A2 Microencapsulation of drugs by solvent exchange |
| 07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | US20030125571 7-hydroxy-3-(4-hydroxyphenyl)-3-methyl-chromene or thiochromene-4-yl)-pentafluoroalkanoic acid or a hydrate useful antiestrogenic or anticarcinogenic agent (breast cancer) |
| 07/03/2003 | US20030125528 Comprises porcine somatotropin and o-vanillin, for improving feed efficiency in swine; opioid analgesics; freeze drying, spray drying; storage stabiity |
| 07/03/2003 | US20030125387 Antioestrogens, capable of eliciting complete ablation of the trophic effects of oestrogens; cancer therapy |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125237 Controlled release preparation of insulin and its method |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124721 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 07/03/2003 | US20030124602 Tumour suppresor and uses thereof |
| 07/03/2003 | US20030124193 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 07/03/2003 | US20030124150 Kit for reducing aching |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124094 Increasing or maintaining the blood supply in the penis |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/02/2003 | EP1322954A1 Method for treatment of insulin resistance in obesity and diabetes |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322663A1 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5- g(a)-androst-1-en-3-one and a process for preparing it |
| 07/02/2003 | EP1322662A1 19-nor-17 alpha-pregna-1,3,5 (10)-trien-17 beta-ols of a 21,16 alpha-lactone ring |
| 07/02/2003 | EP1322660A2 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |